Supports healthy brain and nerve function, especially during aging Provides a metabolic source for the neurotransmitter acetylcholine Aids in cellular energy production for nerve, heart, and muscle cells Supports membrane stability and cerebral blood flow Provided in a stable, hydrochloride form
To assess the associations of semaglutide with recurrent CUD, the study population included 2034 patients who had active medical encounters for the diagnosis of obesity in 6/202112/2022, were for the first time (new users design) prescribed semaglutide or non-GLP-1RA anti-obesity medications during 6/202112/2022 (time zero or index event), had a diagnosis of CUD on or before the index event, and had a diagnosis of at least one of obesity-associated comorbidities on or before the index event
By the 6-month mark, many patients experience 1015% total body weight reduction when combined with lifestyle modifications
It enhances the function of immune cells, aids in detoxifying the liver, and regenerates other antioxidants